medium of the same composition and were cultured on a rotary shaker (220 r.p.m.) at 28 1C for 4 days.
The whole culture broth (2 l) was extracted with an equal volume of n-BuOH. After the n-BuOH layer was evaporated in vacuo, the resulting residue was suspended in brine (350 ml) and then extracted with EtOAc (350 ml Â 3) and n-BuOH (300 ml Â 2), successively. The n-BuOH extract (3.1 g) was subjected to reversed-phase mediumpressure liquid chromatography (Purif-Pack ODS-30, size: 60 (39 g), Shoko Scientific Co., Ltd., Yokohama, Japan) with the UV detection wavelength set at 254 nm. A H 2 O-CH 3 CN stepwise gradient system (100 ml each of 10, 20, 30, 40 and 50% CH 3 CN) was used to eluate 1 (63.2 mg, 40% CH 3 CN). The EtOAc extract (2.4 g) was fractionated by medium-pressure silica gel column chromatography (Purif-Pack SI-30, size: 60 (27 g), Shoko Scientific) using an n-hexane-EtOAc linear gradient system (0-25% EtOAc over 12 min and was kept at 25% for 3 min, flow rate: 20 ml min -1 ) followed by a CHCl 3 -MeOH stepwise gradient system (100 ml each of 0, 2, 5, 10, 20, 30 and 100% MeOH). The 20% MeOH fraction (288.1 mg) was subjected to gel filtration chromatography (Sephadex LH-20, GE Healthcare BioSciences AB, Uppsala, Sweden; 2.5 Â 45 cm) and eluted using CHCl 3 -MeOH (1:1) to afford crude 2 (63.5 mg). The final purification of 2 (11.9 mg) was carried out by reversed-phase HPLC using a CAPCELL PAK C18 MGII column (5.0 mm, 20 Â 150 mm; Shiseido, Tokyo, Japan) with 35% aqueous CH 3 CN containing 0.1% formic acid (flow rate: 10 ml min -1 , retention time: 12.5 min).
MBJ-0034 (1) 1 H and 13 C NMR spectra, respectively. The planar structure of 1 was determined by a series of 2D NMR analyses including double quantum filtered COSY (DQF-COSY), heteronuclear single quantum coherence and constant-time heteronuclear multiple-bond correlation 6 (CT-HMBC). The 13 C and 1 H NMR data of 1 is listed in Table 1 .
The CT-HMBC spectrum showed a 1 H-13 C long-range coupling from a nitrogen-bearing methyl proton H 3 The connectivity among the amino-acid units was determined by 1 H-13 C long-range couplings from H-2, H 2 -10, H 2 -13 and H 2 -15 to C-6, C-11, C-14 and C-16, respectively. The molecular formula indicated the presence of two hydroxamic acid groups in 1. The chemical shift value of C-26 (d C 34.4) suggested that the nitrogen atom connected to C-7 is protonated. 7 Accordingly, the positions of two hydroxamic acid groups were determined to be C-1 (C-5) and C-10 (C-11). Thus, the gross structure of 1 was elucidated, as shown in Figure 1a .
MBJ-0035 (2) was obtained as a colorless amorphous powder:
D -52 (c 0.1, MeOH); UV l max nm (log e): 240 (4.1) and 305 (3.7) in MeOH; IR (ATR) n max 3300 and 1650 cm À1 (hydroxy and carbonyl). The molecular formula of 2 was established as Based on the analyses of 1D and 2D NMR spectra, the partial structure of 2 was found to be the same as that of 1, as shown in Figure 1c . The structural difference between 1 and 2 is an additional phenethylcarbamic acid moiety, whose presence was confirmed by 1 (d C 129.9). Finally, HMBC correlations from an N-methyl proton H 3 -26 (d H 2.77) and a low-field shifted a-methine proton H-7 (d H 4.85) to C-27 indicated that the phenethylcarbamic acid moiety is connected to C-7 by an amide bond. Therefore, the structure of 2 was determined as shown in Figure 1a .
The cytotoxic activities of 1 and 2 against human ovarian adenocarcinoma SKOV-3 cells were examined by using the WST-8 [5-(2,4-disulfophenyl)-3-(2-methoxy-4-nitrophenyl)-2-(4-nitrophenyl) -2H-tetrazolium, monosodium salt] colorimetric assay (Cell Counting Kit; Dojindo, Kumamoto, Japan). After 72 h of treatment, 2 exhibited weak cytotoxic activity against SKOV-3 cells with the IC 50 of 37 mM, whereas 1 exhibited no cytotoxicity (IC 50 450 mM). Since the derivatives of 1 and 2, madurastatin A1 and its congeners were reported to show antibacterial activities against Micrococcus luteus, 7 we evaluated the antimicrobial activities of 1 and 2. As the result, contrary to this report, 1 and 2 did not show antimicrobial activities against M. luteus nor Bacillus subtilis even at the concentrations of 100 mM. Compounds 1 and 2 did not show the antimicrobial activities against Escherichia coli. To the best of our knowledge, peptides with aziridine moiety is extremely rare in nature and have not been reported except for madurastatin A1. The planar structure of 1 appears to be same as madurastatin C1. 8 
